CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
0.890
+0.024 (2.71%)
At close: Nov 22, 2024, 4:00 PM
0.871
-0.019 (-2.18%)
After-hours: Nov 22, 2024, 4:24 PM EST
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $69.65 million as of November 22, 2024. Its market cap has decreased by -18.73% in one year.
Market Cap
69.65M
Enterprise Value
-37.34M
1-Year Change
-18.73%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has decreased from $464.70M to $69.65M, a decrease of -85.01%. That is a compound annual growth rate of -18.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 68.10M | -34.39% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exagen | 72.31M |
| electroCore | 72.27M |
| Vistagen Therapeutics | 71.84M |
| Metagenomi | 70.73M |
| BeyondSpring | 70.12M |
| InspireMD | 69.12M |
| Scilex Holding Company | 68.60M |
| bluebird bio | 68.07M |